Viking Therapeutics director Dorothy Elizabeth Kelly-Gemmell files initial beneficial ownership statement
VKTX•Director files initial Form 3
- Viking Therapeutics director Dorothy Elizabeth Kelly-Gemmell filed an initial Form 3 with the SEC on Aug. 7, 2026.
